Today: 8 November 2025
Subscribe
Browse Tag

buyout

Cheer Holding (CHR) Stock Skyrockets on Buyout Bids – Inside the AI Innovator’s Rollercoaster Ride

Cheer Holding (CHR) Stock Skyrockets on Buyout Bids – Inside the AI Innovator’s Rollercoaster Ride

Company Overview: A Niche Chinese Digital Ecosystem Cheer Holding, Inc. is a China-based provider of advanced mobile internet infrastructure and digital content platforms. Through its subsidiaries, Cheer offers advertising and content production services in the Chinese market. The company has built a suite of consumer apps and services under the “CHEERS” brand, aiming to create an integrated digital ecosystem. Its flagship offerings include CHEERS Video (a short-video and live streaming app), CHEERS e-Mall (an e-commerce platform blending livestream shopping and online games), and CHEERS App which combines professionally-produced content with shopping features. In recent years, Cheer Holding has pivoted heavily
5 November 2025
 ·  ·  ·  · 
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven care en.wikipedia.org. As a spin-off, Kenvue took over J&J’s well-known retail brands, ranging from over-the-counter (OTC) medicines to skincare and baby care. Today its portfolio spans three segments investing.com: Formally incorporated in 2022, Kenvue began trading on the NYSE (ticker KVUE) in May 2023 after a highly anticipated IPO en.wikipedia.org. The IPO raised $3.8 billion – the largest U.S. listing in nearly two years – and
4 November 2025
 ·  ·  ·  ·  ·  ·  · 
Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the year tipranks.com. Evoke Pharma’s stock has experienced extreme volatility in recent weeks. After trading in the mid-$4 to $5 range through October, EVOK plunged 10.9% on November 3, 2025 to $4.59 at the close tipranks.com. The very next day, news of the buyout sent the stock exploding upward – EVOK opened around $10.70 on
4 November 2025
 ·  ·  ·  ·  · 
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact, DENN hit a 52-week low of $2.85 earlier in the year marketbeat.com, reflecting investors’ pessimism about growth prospects. By late October, the stock was trading around the $4 mark, not far from where it stood five years ago, and well off the 52-week high of $7.73 marketbeat.com reached in late 2024. In the week heading into earnings, DENN even dipped
4 November 2025
 ·  ·  ·  · 
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Stock Price and Intraday Performance (Nov 3, 2025) Kenvue’s stock soared on the buyout news, delivering a sharp one-day gain. As of midday Nov. 3, KVUE traded around $17–$18, up roughly 18–20% intraday reuters.com. Prior to the announcement, the stock had closed at $14.37 on Oct. 31 stockanalysis.com, near its 52-week low of ~$14.02 reuters.com reuters.com. The takeover premium (deal valued at ~$21.01 per share) immediately boosted KVUE, though the share price remained a bit below the offer value – typical in cash/stock mergers as arbitragers factor in execution timing and Kimberly-Clark’s own stock movement (KMB shares fell ~12.5% on
3 November 2025
 ·  ·  ·  ·  ·  · 
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar’s LIDAR Rollercoaster: Stock Rockets on Buyout Buzz, Then Plunges Amid Cash Crunch

Stock Performance and Recent Price Action Luminar’s stock has been exceptionally volatile. On Oct. 24, 2025 the shares spiked about 31% (to ~$2.28 intraday) as the market jumped on “buyout buzz” tied to founder Austin Russell’s proposal ts2.tech ts2.tech. That move briefly pushed LAZR above its short-term resistance (~$2.10–$2.25) ts2.tech. However, within days investors were hit with negative news – missed debt payments, a halted production forecast and cash worries – causing the stock to crash. From intraday highs near $2.25 on Oct. 24, LAZR plunged to a one-year low around $1.11 by Oct. 31 ts2.tech. As of Nov. 1 the stock traded roughly
1 November 2025
 ·  ·  ·  · 
Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Bottom Line: Avidity Biosciences’ stock is set to explode higher on Novartis’s $12 billion buyout, capping off a dramatic run fueled by breakthrough science and takeover buzz. The high-premium deal underscores the massive value of RNA therapeutics for rare diseases – and signals that big pharma’s biotech spending spree isn’t slowing down. While Avidity’s chapter as an independent company is closing, its novel treatments may reach patients faster under Novartis’s umbrella. Investors now await the finalization of the deal (and SpinCo details), as Wall Street cheers another biotech success story in the making. 🏥💥 Sources: reuters.com reuters.com business-standard.com biospace.com biospace.com
26 October 2025
 ·  ·  ·  · 
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar Stock Skyrockets 31% on Buyout Buzz – Lidar Boom Back in Spotlight?

Luminar’s LiDAR technology has gained attention as its stock popped in late October 2025. Investors are weighing the firm’s strong auto partnerships against its slim revenue base and recent buyout proposal. Stock Rally and Buyout Speculation Luminar Technologies, a Florida-based maker of long-range automotive LiDAR, has suddenly found itself in the headlines. On Oct. 25, 2025, Luminar’s stock jumped about 31% to roughly $2.22 reuters.com. This surge came amid two key catalysts: a broad tech stock rally and speculation around founder Austin Russell’s plans. According to an SEC filing and media reports, Russell – who was ousted as CEO in
25 October 2025
 ·  ·  ·  ·  · 
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr (GRND) Stock Explodes on $18 Buyout Buzz – Is a $3.5B Takeover Coming?

Stock Reaction and Trading Activity On Friday Oct 24, GRND shot up from the low-$12 range into the mid-$15s. Finviz data show Friday’s prevailing price was $12.67 with the stock closing at $15.06 (a +18.86% jump) finviz.com. Investing.com and TechStock² report intraday spikes to ~$16 (after the $18 bid was revealed) before settling near $15 ts2.tech investing.com. Trading volume was ~11.4 M shares on Friday – roughly five times the 6-week average – reflecting the frenzied demand finviz.com. In short, the buyout news sent GRND soaring. By contrast, peers like Bumble and Match saw only modest moves. (Note: U.S. markets were closed
25 October 2025
 ·  ·  ·  ·  · 
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Buyout Buzz Sends GRND Soaring Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s close investing.com. The rally came after Grindr confirmed that its two largest shareholders – board Chair James Fu Bin Lu and director G. Raymond Zage III – had submitted a preliminary proposal to take the company private at $18.00 per share in cash d18rn0p25nwr6d.cloudfront.net d18rn0p25nwr6d.cloudfront.net. By the end of the day, Grindr stock was hovering around $15.90 (up ~25.6%) on
24 October 2025
 ·  ·  ·  ·  · 
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes Buyout Sparks Rally in AVDL Stock On Oct. 22, 2025, Alkermes announced it would acquire Avadel for $18.50 cash per share plus a $1.50 contingent value right (CVR) tied to an FDA approval for idiopathic hypersomnia, valuing the deal at up to $2.1 billion prnewswire.com. The all-cash offer represents roughly a 12% premium to Avadel’s recent trading range. Avadel CEO Greg Divis hailed the terms as “a compelling outcome for our shareholders” prnewswire.com, while Alkermes CEO Richard Pops said the deal is “a pivotal step” to accelerate Alkermes’ entry into the sleep-medicine market prnewswire.com. Avadel’s board and Alkermes’ board have
22 October 2025
 ·  ·  ·  ·  ·  ·  · 
Shocking Surge: Hillenbrand Stock Soars 19% on $32 Buyout Announcement

Shocking Surge: Hillenbrand Stock Soars 19% on $32 Buyout Announcement

Lone Star Buyout Details Hillenbrand (NYSE: HI) announced on Oct. 15 that it will be acquired by Lone Star Funds in an all-cash deal at $32.00 per share ir.hillenbrand.com. At this price, the transaction’s enterprise value is roughly $3.8 billion, including Hillenbrand’s debt. The board said it reviewed multiple strategic options and unanimously determined the offer “is in the best interest of Hillenbrand and its shareholders” ir.hillenbrand.com. Lone Star’s offer represents a 37% premium to Hillenbrand’s pre-deal share price on Aug. 12 ir.hillenbrand.com, and 53% above the 90-day average price up to that date. The companies expect the deal to close by
15 October 2025
 ·  ·  ·  ·  · 
1 2
Go toTop